• Issue

    Hematological Oncology: Volume 38, Issue 5

    1-837
    December 2020
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 1-2
  • First Published: 29 December 2020

REVIEWS

Precision medicine in follicular lymphoma: Focus on predictive biomarkers

Marc Sorigue,  Eloi Cañamero,  Juan-Manuel Sancho, 
  • Pages: 625-639
  • First Published: 23 July 2020

INVITED REVIEW

On point in primary CNS lymphoma

Mazie Tsang,  Joseph Cleveland,  James L. Rubenstein, 
  • Pages: 640-647
  • First Published: 08 June 2020

REVIEWS

Should we screen patients with hematologic malignancies for COVID-19?

Elie Rassy,  Rita-Maria Khoury-Abboud,  Nathalie Ibrahim,  Tarek Assi,  Bachar Samra,  Colette Hanna,  Fadi El Karak,  Marwan Ghosn, 
  • Pages: 648-653
  • First Published: 19 July 2020

PERSPECTIVES

Open Access

Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies

Tariq I. Mughal,  Naveen Pemmaraju,  Bethan Psaila,  Jerald Radich,  Prithviraj Bose,  Thomas Lion,  Jean-Jacques Kiladjian,  Raajit Rampal,  Tania Jain,  Srdnan Verstovsek,  Abdulraheem Yacoub,  Jorge E. Cortes,  Ruben Mesa,  Giuseppe Saglio,  Richard A. van Etten, 
  • Pages: 654-664
  • First Published: 27 June 2020

ORIGINAL RESEARCH ARTICLES

Prognostic significance of histologic grade and Ki-67 proliferation index in follicular lymphoma

Tian Xue,  Bao-Hua Yu,  Wan-Hui Yan,  Xiang-Nan Jiang,  Tian Tian,  Xiao-Yan Zhou,  Xiao-Qiu Li, 
  • Pages: 665-672
  • First Published: 06 July 2020

Cytokine-related genes play critical roles in extrafollicular growth of follicular lymphoma cells

Noriaki Yoshida,  Hiroaki Miyoshi,  Fumiko Arakawa,  Kazutaka Nakashima,  Keisuke Kawamoto,  Masao Seto,  Koichi Ohshima, 
  • Pages: 673-679
  • First Published: 24 August 2020

Clinicopathological analysis of immunohistochemical expression of CD47 and SIRPα in adult T-cell leukemia/lymphoma

Eriko Yanagida,  Hiroaki Miyoshi,  Mai Takeuchi,  Noriaki Yoshida,  Kazutaka Nakashima,  Kyohei Yamada,  Takeshi Umeno,  Yasumasa Shimasaki,  Takuya Furuta,  Masao Seto,  Koichi Ohshima, 
  • Pages: 680-688
  • First Published: 22 June 2020

Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis

Irene Defrancesco,  Silvia Zibellini,  Emanuela Boveri,  Marco Frigeni,  Virginia Valeria Ferretti,  Ettore Rizzo,  Arturo Bonometti,  Francesca Capuano,  Chiara Candido,  Sara Rattotti,  Annamaria Tenore,  Cristina Picone,  Elena Flospergher,  Caterina Zerbi,  Fabio Bergamini,  Nicole Fabbri,  Caterina Cristinelli,  Marzia Varettoni,  Marco Paulli,  Luca Arcaini, 
  • Pages: 689-697
  • First Published: 01 August 2020

Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma

Irene Della Starza,  Lucia Anna De Novi,  Marzia Cavalli,  Noemi Novelli,  Roberta Soscia,  Elisa Genuardi,  Barbara Mantoan,  Daniela Drandi,  Martina Ferrante,  Luigia Monitillo,  Daniela Barbero,  Elena Ciabatti,  Susanna Grassi,  Riccardo Bomben,  Massimo Degan,  Valter Gattei,  Sara Galimberti,  Alice Di Rocco,  Maurizio Martelli,  Sergio Cortelazzo,  Anna Guarini,  Robin Foà,  Marco Ladetto,  Simone Ferrero,  Ilaria Del Giudice, on behalf of the Fondazione Italiana Linfomi (FIL) MRD Network , 
  • Pages: 698-704
  • First Published: 20 August 2020

Combining T-cell-based immunotherapy with venetoclax elicits synergistic cytotoxicity to B-cell lines in vitro

Satsuki Murakami,  Susumu Suzuki,  Ichiro Hanamura,  Kazuhiro Yoshikawa,  Ryuzo Ueda,  Masao Seto,  Akiyoshi Takami, 
  • Pages: 705-714
  • First Published: 21 August 2020

Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B-cell lymphoma: post-hoc analysis from the SAKK38/07 clinical trial

Emanuele Zucca,  Luciano Cascione,  Teresa Ruberto,  Davide Facchinelli,  Sämi Schär,  Stefanie Hayoz,  Stefan Dirnhofer,  Luca Giovanella,  Mario Bargetzi,  Christoph Mamot,  Luca Ceriani, 
  • Pages: 715-725
  • First Published: 18 September 2020

Low-dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource-constrained setting

Thomas S. Y. Chan,  Yu-Yan Hwang,  Pek-Lan Khong,  Anskar Y. H. Leung,  Chor-Sang Chim,  Eric W. C. Tse,  Yok-Lam Kwong, 
  • Pages: 726-736
  • First Published: 12 August 2020

Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience

Beatrice Casadei,  Lisa Argnani,  Alice Morigi,  Ginevra Lolli,  Alessandro Broccoli,  Cinzia Pellegrini,  Laura Nanni,  Vittorio Stefoni,  Paolo Elia Coppola,  Matteo Carella,  Michele Cavo,  Pier Luigi Zinzani, 
  • Pages: 737-741
  • First Published: 09 September 2020

Clinical significance of tryptophan catabolism in follicular lymphoma

Ayako Masaki,  Takashi Ishida,  Yasuhiro Maeda,  Asahi Ito,  Susumu Suzuki,  Tomoko Narita,  Shiori Kinoshita,  Takashi Yoshida,  Masaki Ri,  Shigeru Kusumoto,  Hirokazu Komatsu,  Hiroshi Inagaki,  Ryuzo Ueda,  Ilseung Choi,  Youko Suehiro,  Shinsuke Iida, 
  • Pages: 742-753
  • First Published: 17 September 2020

Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia

Erika Borlenghi,  Chiara Cattaneo,  Elisa Cerqui,  Silvana Archetti,  Diego Bertoli,  Daniela Bellotti,  Doriana Gramegna,  Giulia Soverini,  Margherita Oberti,  Francesca Schieppati,  Chiara Pagani,  Angela Passi,  Margherita Sciumé,  Mirko Farina,  Cecilia Carbone,  Claudia Crippa,  Daniela Dalceggio,  Alessandra Tucci,  Giuseppe Rossi, 
  • Pages: 754-762
  • First Published: 19 September 2020

Pediatric randomized trial EORTC CLG 58951: Outcome for adolescent population with acute lymphoblastic leukemia

Laura Olivier-Gougenheim,  Chloe Arfeuille,  Stefan Suciu,  Nicolas Sirvent,  Geneviève Plat,  Alina Ferster,  Barbara de Moerloose,  Carine Domenech,  Anne Uyttebroeck,  Pierre-Simon Rohrlich,  Helene Cavé,  Yves Bertrand, 
  • Pages: 763-772
  • First Published: 18 August 2020

Targeted-dose of busulfan: Higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol⸱min. A historically controlled clinical trial

Iracema Esteves,  Fabio Pires Souza Santos,  Andreza Alice Feitosa Ribeiro,  Adriana Seber,  Eduardo Kinio Sugawara,  Jairo José do Nascimento Sobrinho,  José Carlos Barros,  José Salvador Rodrigues Oliveira,  Juliana Folloni Fernandes,  Nelson Hamerschlak,  Borje S. Andersson,  Marcos de Lima,  Fabio Rodrigues Kerbauy, 
  • Pages: 773-781
  • First Published: 11 August 2020

Kinetics of pre-myelodysplastic syndromes blood values correlate with disease risk and survival

Erel Joffe,  Uri Greenbaum,  Gili Man-El,  Kalman Filanovsky,  Howard S. Oster,  Itai Levi,  Pia Raanani,  Irit Avivi,  Moshe Mittelman, 
  • Pages: 782-791
  • First Published: 07 July 2020

A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)—AGMT_CML 1

Sonja Heibl,  Veronika Buxhofer-Ausch,  Stefan Schmidt,  Gerald Webersinke,  Thomas Lion,  Gudrun Piringer,  Thomas Kuehr,  Dominik Wolf,  Thomas Melchardt,  Richard Greil,  Josef Thaler, 
  • Pages: 792-798
  • First Published: 05 August 2020

Association of Epstein–Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases

Katsuya Fujimoto,  Kanako C. Hatanaka,  Yutaka Hatanaka,  Ikumi Kasahara,  Satoshi Yamamoto,  Takahiro Tsuji,  Masanobu Nakata,  Yasunari Takakuwa,  Yoshihito Haseyama,  Yumiko Oyamada,  Masakatsu Yonezumi,  Hiroaki Suzuki,  Hajime Sakai,  Hiroko Noguchi,  Akio Mori,  Hiroshi Nishihara,  Takanori Teshima,  Yoshihiro Matsuno, 
  • Pages: 799-807
  • First Published: 15 August 2020

Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia

Syed Khizer Hasan,  Nikhil V. Patkar,  Deepan Rajamanickam,  Anant Gokarn,  Antonio R. Lucena-Araujo,  Prashant Tembhare,  Bhausaheb Bagal,  Pratibha Kadam Amare,  Hasmukh Jain,  Sumeet Gujral,  Manju Sengar,  Papagudi Ganesan Subramanian,  Navin Khattry, 
  • Pages: 808-816
  • First Published: 07 September 2020

CASE REPORTS

Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma?

Andrew M. Parrott,  Aya M. Haggiagi,  Vundavalli V. Murty,  Govind Bhagat,  Bachir Alobeid, 
  • Pages: 817-822
  • First Published: 08 July 2020

Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature

Andrea Visentin,  Silvia Imbergamo,  Valentina Trimarco,  Stefano Pravato,  Leila Romano Gargarella,  Federica Frezzato,  Greta Scapinello,  Roberta Bertorelle,  Elisa Piva,  Monica Facco,  Gianpietro Semenzato,  Francesco Piazza,  Livio Trentin, 
  • Pages: 823-826
  • First Published: 26 September 2020

LETTER TO THE EDITOR

Cancer testis antigen expression across T-cell lymphoma subtypes

Helen Ma,  Craig R. Soderquist,  Enrica Marchi,  Luigi Scotto,  Govind Bhagat,  Owen A. O'Connor, 
  • Pages: 827-830
  • First Published: 03 August 2020

MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma

Maria Rosaria Sapienza,  Fabio Fuligni,  Federica Melle,  Valentina Tabanelli,  Valentina Indio,  Maria Antonella Laginestra,  Giovanna Motta,  Saveria Mazzara,  Lorenzo Cerroni,  Alessandro Pileri,  Fabio Facchetti,  Marco Paulli,  Luciano Cascione,  Alessandro Laganà,  Emilio Berti,  Manuela Ferracin,  Claudio Agostinelli,  Elena Sabattini,  Carlo Maria Croce,  Stefano Aldo Pileri, 
  • Pages: 831-833
  • First Published: 30 July 2020

Salvage therapy with decitabine in combination with granulocyte colony-stimulating factor, low-dose cytarabine, and aclarubicin in patients with refractory or relapsed early T-cell precursor acute lymphoblastic leukemia

Tongyan Meng,  Yao Yao,  Yang Xu,  Shengli Xue,  Yue Han,  Xiaowen Tang,  Huiying Qiu,  Aining Sun,  Depei Wu,  Yanming Zhang,  Ying Wang, 
  • Pages: 834-837
  • First Published: 25 July 2020